Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanya Simuni

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Expert Review of Clinical Pharmacology|August 19, 2017
Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosisYasaman Kianirad, Tanya Simuni
Annals of Neurology|January 8, 2009
Nonmotor manifestations of Parkinson's diseaseTanya Simuni, Kapil Sethi
Current Neurology and Neuroscience Reports|February 23, 2016
Novel Approaches to Optimization of Levodopa Therapy for Parkinson's DiseaseYasaman Kianirad, Tanya Simuni
Current Neurology and Neuroscience Reports|August 3, 2020
Infusion Therapies for Parkinson's DiseaseNeha Prakash, Tanya Simuni
Journal of Parkinson'S Disease|April 22, 2014
Is exenatide the next big thing in Parkinson's disease?Tanya Simuni, Patrik Brundin
Neuropharmacology|November 7, 2021
New dopaminergic therapies for PD motor complicationsDanielle Larson, Tanya Simuni
Expert Opinion on Investigational Drugs|September 18, 2014
Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson's diseaseAnna R Carta, Tanya Simuni
Parkinsonism & Related Disorders|November 5, 2018
New Era in disease modification in Parkinson's disease: Review of genetically targeted therapeuticsS Pablo Sardi, Tanya Simuni
Handbook of Clinical Neurology|February 21, 2023
Role of novel endpoints and evaluations of response in Parkinson diseaseLana M Chahine, Tanya Simuni
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2009
Effect of movement frequency on repetitive finger movements in patients with Parkinson's diseaseElizabeth L Stegemöller, Tanya Simuni, Colum MacKinnon
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Expert Review of Clinical Pharmacology|August 19, 2017
Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosisYasaman Kianirad, Tanya Simuni
Annals of Neurology|January 8, 2009
Nonmotor manifestations of Parkinson's diseaseTanya Simuni, Kapil Sethi
Current Neurology and Neuroscience Reports|February 23, 2016
Novel Approaches to Optimization of Levodopa Therapy for Parkinson's DiseaseYasaman Kianirad, Tanya Simuni
Current Neurology and Neuroscience Reports|August 3, 2020
Infusion Therapies for Parkinson's DiseaseNeha Prakash, Tanya Simuni
Journal of Parkinson'S Disease|April 22, 2014
Is exenatide the next big thing in Parkinson's disease?Tanya Simuni, Patrik Brundin
Neuropharmacology|November 7, 2021
New dopaminergic therapies for PD motor complicationsDanielle Larson, Tanya Simuni
Expert Opinion on Investigational Drugs|September 18, 2014
Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson's diseaseAnna R Carta, Tanya Simuni
Parkinsonism & Related Disorders|November 5, 2018
New Era in disease modification in Parkinson's disease: Review of genetically targeted therapeuticsS Pablo Sardi, Tanya Simuni
Handbook of Clinical Neurology|February 21, 2023
Role of novel endpoints and evaluations of response in Parkinson diseaseLana M Chahine, Tanya Simuni
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2009
Effect of movement frequency on repetitive finger movements in patients with Parkinson's diseaseElizabeth L Stegemöller, Tanya Simuni, Colum MacKinnon
Pageof 20